Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: mammoliti s. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Crossover study with cisplatin or carboplatin in advanced ovarian cancer.
Repetto L, Chiara S, Mammoliti S, Guido T, Bruzzone M, Secondo V, Donadio G, Odicino F, Ragni N, Conte PF, et al. Repetto L, et al. Among authors: mammoliti s. Gynecol Oncol. 1990 Nov;39(2):146-9. doi: 10.1016/0090-8258(90)90422-h. Gynecol Oncol. 1990. PMID: 2227588 Clinical Trial.
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
Conte PF, Bruzzone M, Carnino F, Gadducci A, Algeri R, Bellini A, Boccardo F, Brunetti I, Catsafados E, Chiara S, Foglia G, Gallo L, Iskra L, Mammoliti S, Parodi G, Ragni N, Rosso R, Rugiati S, Rubagotti A. Conte PF, et al. Among authors: mammoliti s. J Clin Oncol. 1996 Feb;14(2):351-6. doi: 10.1200/JCO.1996.14.2.351. J Clin Oncol. 1996. PMID: 8636743 Clinical Trial.
Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients.
Bruzzone M, Catsafados E, Miglietta L, Amoroso D, Pedulla F, Giannessi PG, Locatelli MC, D'Antona A, Foglia G, Mammoliti S, Turno F, Gentile A, Nicosia F, Luporini G, Ragni N, Boccardo F. Bruzzone M, et al. Among authors: mammoliti s. Oncology. 1996 Sep-Oct;53(5):349-53. doi: 10.1159/000227586. Oncology. 1996. PMID: 8784466 Clinical Trial.
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
Miglietta L, Amoroso D, Bruzzone M, Granetto C, Catsafados E, Mammoliti S, Guarneri D, Pedulla F, Foglia G, Ragni N, Martini MC, Brema F, Addamo G, Moraglio L, Pastorino G, Boccardo F. Miglietta L, et al. Among authors: mammoliti s. Oncology. 1997 Mar-Apr;54(2):102-7. doi: 10.1159/000227671. Oncology. 1997. PMID: 9075779 Clinical Trial.
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest.
Bruzzone M, Rubagotti A, Gadducci A, Catsafados E, Foglia G, Brunetti I, Giannessi PG, Carnino F, Iskra L, Rosso R, Martoni A, Pannuti F, De Lisi V, Maltoni R, Ridolfi R, Mammoliti S, Gallo L, Boccardo F, Ragni N, Conte PF. Bruzzone M, et al. Among authors: mammoliti s. Gynecol Oncol. 1997 Jun;65(3):499-505. doi: 10.1006/gyno.1997.4689. Gynecol Oncol. 1997. PMID: 9190982 Clinical Trial.
First-line single-agent cetuximab in patients with advanced colorectal cancer.
Pessino A, Artale S, Sciallero S, Guglielmi A, Fornarini G, Andreotti IC, Mammoliti S, Comandini D, Caprioni F, Bennicelli E, Andretta V, Siena S, Sobrero A. Pessino A, et al. Among authors: mammoliti s. Ann Oncol. 2008 Apr;19(4):711-6. doi: 10.1093/annonc/mdm516. Epub 2007 Dec 10. Ann Oncol. 2008. PMID: 18073221 Free article. Clinical Trial.
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.
Mammoliti S, Andretta V, Bennicelli E, Caprioni F, Comandini D, Fornarini G, Guglielmi A, Pessino A, Sciallero S, Sobrero AF, Mazzola G, Lambiase A, Bordignon C. Mammoliti S, et al. Ann Oncol. 2011 Apr;22(4):973-978. doi: 10.1093/annonc/mdq436. Epub 2010 Sep 20. Ann Oncol. 2011. PMID: 20855468 Free PMC article. Clinical Trial.
65 results